TEST BANK mk
For Pharmacology Clear and Simple:
mk mk mk mk
A Guide to Drug Classifications and Dosage Calculation
mk mk mk mk mk mk mk
s,
4th Edition by Cynthia J. Watkins
mk mk mk mk mk
Chapters 1 - 21 mk mk mk
,
,Chaptermk 1.mk Historymk ofmk Pharmacology
PharmacologymkClearmkandmkSimple-
mkAmkGuidemktomkDrugmkClassificationsmkandmkDosage mkCalculationsmk4thm
EditionmkWatkinsmkTestmkB
k
ank
1.
Amk nursem k workingmk inmk radiologymk administersmk iodinemk tomk am k patientmk whomk ismk havin
gmk amkcomputedmtk omographymk(CT)mk scan.mk Themk nursemk workingmk onmk themk oncologymk unit
mkadministersmkchemotherapymk tom k patientsmk whomk havem k cancer.m k Atm k themk Publicm k Health
mkDepartment,m k am k nursemkadministersm k am k measles-mumps-
rubellam k (MMR)m k vaccinemktomkamk 14-month-
oldmkchildmk asmk amkroutinemk immunization.mk Whichmkbranchmk ofmkpharmacologymkbestmk desc
ribesmkthemkactionsmkofmkallmkthreemknurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacologymk ismk themk studymk ofmk themk biologicmk effectsmk ofmk chemicals.mk Nursesmk aremkin
volvedmkwithm k clinicalm k pharmacologymk orm k pharmacotherapeutics,m k whichm k ismk amkbranch
mk ofmkpharmacologymk thatmk dealsmk withmk themk usesmk ofmk drugsmk tomk treat,mk prevent,mkandmk dia
gnosemk disease. mTk hemk radiologymk nursemk ismk administeringmk amk drugmk tomk helpmkdiagnosem k a
m k disease.mk Themk oncologymknursemk ismk administeringmk amk drugmk tomk helpmk treatmkam k disease.
m k Pharmacoeconomicsm k includesm k anymkcostsmk involvedm k inm k drugmk therapy.mkPharmacody
namicsmk involvesmkhowmkamk drugmkaffectsmkthemkbodymkandmkpharmacokineticsmkismk howmkthe
mkbodymkactsmkonmkthemkbody.
2.
Amk physicianmk hasmk orderedmkintramuscularmk(IM)mk injectionsmk ofmk morphine
,mk amknarcotic,mk everymk4mk hoursmk asmk neededmk formk painmk inmkamk motormk vehiclemk
accidentmkvictim.mk Themk nursemk ismk awarem k thismk drugmk hasmk amk highmk abusem k po
tential.mk Undermk whatmck ategorymkwouldmkmorphinemkbemkclassified?
A) Schedulemk I
B) Schedulemk II
C) Schedulemk III
D) Schedulemk IV
ANSWER: B
, Feedback:
Narcoticsmk withmk amkhighmk abusemk potentialmk aremk classifiedmk asmk SchedulemkIImkdr
ugsmkbecausemk ofmk severemk dependencemk liability.mk Schedulemk Imkdrugsmk havemk hi
ghmk abusemkpotentialm k andm k nomk acceptedmk medicalm k use.mk Schedulemk IIIm k drugsm
k havem k am k lessermkabusemk potentialm k thanmk IImk andmk anmk acceptedm k medicalmk use.m
k Schedulemk IVmk drugsmk havem lk owmk abusemkpotentialmkandmklimitedmk dependencemkl
iability.
3.
Whenm k involvedmk inm k phasem k IIImk drugm k evaluationm k studies,m k whatmk resp
onsibilitiesmw
k ouldmkthemknursemkhave?
A) Workingmk withmk animalsmk whomk arem k givenmk experimentalm k drugs
B) Choosingmk appropriatem k patientsmk tomk bemk involvedmk inmk themk drugmk study
C) Monitoringmk andm k observingmk patientsm k closelymk form k adversemk effects
D) Conductingm k researchm k tomk determinem k effectivenessm k ofm k them k drug
ANSWER: C
Feedback:
Phasemk IIImk studiesmk involvemk usemk ofmk amk drugmk inmk amk vastmk clinicalmk population
mk inmk whichm pk atientsmk aremk askedmk tom k recordmk anymk symptomsmk theymk experience
m k whilemk takingmk them dk rugs.mk Nursesmk maymkbemk responsiblemk formk helpingmk colle
ctmk andmk analyzemk themkinformationmk tomk bemk sharedmk withmk themk Foodmk andmk Dru
gmk Administrationmk (FDA)mk butmw k ouldm k notmk conductm k researchm k independently
mk becausem k nursesmk dom k notmk prescribemkmedications.mk Usemk ofmk animalsmk inmk dr
ugmk testingmk ismk donemk inmk them k preclinicalmk trials.mkSelectmk patientsmk whomk aremk i
nvolvedmk inmk phasemk IImk studiesmk tomk participatemk inmk studiesmkwheremk themk partic
ipantsmk havemk themk diseasem k themk drugmk ismk intendedmk tomk treat.mk Thesemkpatientsm
k aremk monitoredmk closelymk formk drugmk actionmk andmk adversemk effects.mk Phasemk Imks
tudiesmk involvemk healthymk humanmk volunteersmk whomk aremk usuallymkpaidmkformk th
eirmkparticipation.mk Nursesmkmaymkobservemk formk adversemk effectsmk andmk toxicity.
4.
Whatm k conceptmk ismk consideredmk whenmk genericmk drugsmk arem k substitutedm
k formk brandmnk amemkdrugs?
A) Bioavailability
B) Criticalm k concentration
C) Distribution
D) Half-life
ANSWER: A
Feedback:
For Pharmacology Clear and Simple:
mk mk mk mk
A Guide to Drug Classifications and Dosage Calculation
mk mk mk mk mk mk mk
s,
4th Edition by Cynthia J. Watkins
mk mk mk mk mk
Chapters 1 - 21 mk mk mk
,
,Chaptermk 1.mk Historymk ofmk Pharmacology
PharmacologymkClearmkandmkSimple-
mkAmkGuidemktomkDrugmkClassificationsmkandmkDosage mkCalculationsmk4thm
EditionmkWatkinsmkTestmkB
k
ank
1.
Amk nursem k workingmk inmk radiologymk administersmk iodinemk tomk am k patientmk whomk ismk havin
gmk amkcomputedmtk omographymk(CT)mk scan.mk Themk nursemk workingmk onmk themk oncologymk unit
mkadministersmkchemotherapymk tom k patientsmk whomk havem k cancer.m k Atm k themk Publicm k Health
mkDepartment,m k am k nursemkadministersm k am k measles-mumps-
rubellam k (MMR)m k vaccinemktomkamk 14-month-
oldmkchildmk asmk amkroutinemk immunization.mk Whichmkbranchmk ofmkpharmacologymkbestmk desc
ribesmkthemkactionsmkofmkallmkthreemknurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacologymk ismk themk studymk ofmk themk biologicmk effectsmk ofmk chemicals.mk Nursesmk aremkin
volvedmkwithm k clinicalm k pharmacologymk orm k pharmacotherapeutics,m k whichm k ismk amkbranch
mk ofmkpharmacologymk thatmk dealsmk withmk themk usesmk ofmk drugsmk tomk treat,mk prevent,mkandmk dia
gnosemk disease. mTk hemk radiologymk nursemk ismk administeringmk amk drugmk tomk helpmkdiagnosem k a
m k disease.mk Themk oncologymknursemk ismk administeringmk amk drugmk tomk helpmk treatmkam k disease.
m k Pharmacoeconomicsm k includesm k anymkcostsmk involvedm k inm k drugmk therapy.mkPharmacody
namicsmk involvesmkhowmkamk drugmkaffectsmkthemkbodymkandmkpharmacokineticsmkismk howmkthe
mkbodymkactsmkonmkthemkbody.
2.
Amk physicianmk hasmk orderedmkintramuscularmk(IM)mk injectionsmk ofmk morphine
,mk amknarcotic,mk everymk4mk hoursmk asmk neededmk formk painmk inmkamk motormk vehiclemk
accidentmkvictim.mk Themk nursemk ismk awarem k thismk drugmk hasmk amk highmk abusem k po
tential.mk Undermk whatmck ategorymkwouldmkmorphinemkbemkclassified?
A) Schedulemk I
B) Schedulemk II
C) Schedulemk III
D) Schedulemk IV
ANSWER: B
, Feedback:
Narcoticsmk withmk amkhighmk abusemk potentialmk aremk classifiedmk asmk SchedulemkIImkdr
ugsmkbecausemk ofmk severemk dependencemk liability.mk Schedulemk Imkdrugsmk havemk hi
ghmk abusemkpotentialm k andm k nomk acceptedmk medicalm k use.mk Schedulemk IIIm k drugsm
k havem k am k lessermkabusemk potentialm k thanmk IImk andmk anmk acceptedm k medicalmk use.m
k Schedulemk IVmk drugsmk havem lk owmk abusemkpotentialmkandmklimitedmk dependencemkl
iability.
3.
Whenm k involvedmk inm k phasem k IIImk drugm k evaluationm k studies,m k whatmk resp
onsibilitiesmw
k ouldmkthemknursemkhave?
A) Workingmk withmk animalsmk whomk arem k givenmk experimentalm k drugs
B) Choosingmk appropriatem k patientsmk tomk bemk involvedmk inmk themk drugmk study
C) Monitoringmk andm k observingmk patientsm k closelymk form k adversemk effects
D) Conductingm k researchm k tomk determinem k effectivenessm k ofm k them k drug
ANSWER: C
Feedback:
Phasemk IIImk studiesmk involvemk usemk ofmk amk drugmk inmk amk vastmk clinicalmk population
mk inmk whichm pk atientsmk aremk askedmk tom k recordmk anymk symptomsmk theymk experience
m k whilemk takingmk them dk rugs.mk Nursesmk maymkbemk responsiblemk formk helpingmk colle
ctmk andmk analyzemk themkinformationmk tomk bemk sharedmk withmk themk Foodmk andmk Dru
gmk Administrationmk (FDA)mk butmw k ouldm k notmk conductm k researchm k independently
mk becausem k nursesmk dom k notmk prescribemkmedications.mk Usemk ofmk animalsmk inmk dr
ugmk testingmk ismk donemk inmk them k preclinicalmk trials.mkSelectmk patientsmk whomk aremk i
nvolvedmk inmk phasemk IImk studiesmk tomk participatemk inmk studiesmkwheremk themk partic
ipantsmk havemk themk diseasem k themk drugmk ismk intendedmk tomk treat.mk Thesemkpatientsm
k aremk monitoredmk closelymk formk drugmk actionmk andmk adversemk effects.mk Phasemk Imks
tudiesmk involvemk healthymk humanmk volunteersmk whomk aremk usuallymkpaidmkformk th
eirmkparticipation.mk Nursesmkmaymkobservemk formk adversemk effectsmk andmk toxicity.
4.
Whatm k conceptmk ismk consideredmk whenmk genericmk drugsmk arem k substitutedm
k formk brandmnk amemkdrugs?
A) Bioavailability
B) Criticalm k concentration
C) Distribution
D) Half-life
ANSWER: A
Feedback:
